2020
DOI: 10.3201/eid2602.191453
|View full text |Cite
|
Sign up to set email alerts
|

Characteristics of Patients with Acute Flaccid Myelitis, United States, 2015–2018

Abstract: In support of improving patient care, this activity has been planned and implemented by Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Medscape, LLC designates this Journal-based CME activity for a maximum of 1.00 AMA PRA Category 1 Credit(… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
40
0
1

Year Published

2020
2020
2023
2023

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 29 publications
(46 citation statements)
references
References 33 publications
4
40
0
1
Order By: Relevance
“…The median age at presentation reported in the United States and Europe from 2014 to 2018 ranged from 4.0 to 7.8 years. Though the age range of cases extends into young adulthood, the vast majority of cases have been in children younger than 10 years ( 192 , 198 ). EV-D68 infections are thought to be widespread, as suggested by a high rate of mild infections found on prospective surveillance ( 74 ).…”
Section: Epidemiologymentioning
confidence: 99%
“…The median age at presentation reported in the United States and Europe from 2014 to 2018 ranged from 4.0 to 7.8 years. Though the age range of cases extends into young adulthood, the vast majority of cases have been in children younger than 10 years ( 192 , 198 ). EV-D68 infections are thought to be widespread, as suggested by a high rate of mild infections found on prospective surveillance ( 74 ).…”
Section: Epidemiologymentioning
confidence: 99%
“…Yield of EV/RV and EV-D68 testing among AFM patients is dependent on timing and type of specimen collection and is higher among respiratory specimens collected within 5-7 days of respiratory or febrile illness onset (8,9). Of note, EV-D68 was not detected in specimens from any patients with onset during the nonpeak years of 2015 and 2017, suggesting that EV-D68 is playing a role in the increases in AFM cases every 2 years but plays less of a role during nonpeak years (17).…”
Section: Online Reportmentioning
confidence: 96%
“…The clinical manifestations and epidemiology of confirmed AFM cases strongly suggests an infectious etiology, probably viral. Most AFM cases are in patients with prodromal symptoms consistent with a viral illness before onset of limb weakness, and AFM patients in peak years are significantly more likely to have prodromal respiratory illness or fever than those in nonpeak years (9,10,17). In addition, the increase in AFM noted in 2014 coincided with an unusual increase in severe respiratory illness caused by enterovirus D68 (EV-D68) in the United States; 11 (20%) of 56 AFM patients whose respiratory specimens were tested at CDC in 2014 were positive for EV-D68 (8,18).…”
Section: Online Reportmentioning
confidence: 99%
See 2 more Smart Citations